Graham P. Allaway

8.0k citations

47 papers · 6.6k indexed · 3 hit papers · h-index 30

Virology top 0.05%
Immunology top 0.5%
Infectious Diseases top 0.5%
Molecular Biology top 5%
Epidemiology top 5%

Co-authors: Paul J. Maddon Tatjana Dragic Kirsten Nagashima Richard A. Koup Virginia Litwin William A. Paxton JOHN P. MOORE Yaoxing Huang
Topics: HIV Research and Treatment (22 papers)HIV/AIDS drug development and treatment (19 papers)Immune Cell Function and Interaction (11 papers)
Cited by: Virology Immunology Infectious Diseases
Journals: Nature Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States Canada United Kingdom

In The Last Decade

Graham P. Allaway

46 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

1996 2.6k citations Tatjana Dragic, Virginia Litwin et al. Nature profile →
CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5

1996 922 citations Alexandra Trkola, Tatjana Dragic et al. Nature profile →
AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor

1998 634 citations Dominique Schols, Steven Lin et al. Nature Medicine profile →

Peers

Countries citing papers authored by Graham P. Allaway

Since Specialization

Citations

This map shows the geographic impact of Graham P. Allaway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graham P. Allaway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graham P. Allaway more than expected).

Fields of papers citing papers by Graham P. Allaway

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graham P. Allaway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graham P. Allaway. The network helps show where Graham P. Allaway may publish in the future.

Co-authorship network of co-authors of Graham P. Allaway

This figure shows the co-authorship network connecting the top 25 collaborators of Graham P. Allaway. A scholar is included among the top collaborators of Graham P. Allaway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graham P. Allaway. Graham P. Allaway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design and development of innovative microparticulate/nanoparticulate inhalable dry powders of a novel synthetic trifluorinated chalcone derivative and Nrf2 agonist 2020 ·Scientific Reports ·Priya Muralidharan,(unknown),Graham P. Allaway,Shyam Biswal,Heidi M. Mansour	7
2	Nrf2 exerts cell-autonomous antifibrotic effects: compromised function in systemic sclerosis and therapeutic rescue with a novel heterocyclic chalcone derivative 2016 ·Translational research ·Jun Wei,Hongyan Zhu,(unknown),(unknown),(unknown),Graham P. Allaway,Shyam Biswal,Benjamin D. Korman,Roberta Gonçalves Marangoni,Warren G. Tourtellotte,John Varga	29
3	Elevated temperature triggers human respiratory syncytial virus F protein six-helix bundle formation 2009 ·Virology ·Abdul S. Yunus,(unknown),(unknown),(unknown),Nicole Kilgore,(unknown),Graham P. Allaway,Carl Wild,Karl Salzwedel	35
4	Anti-AIDS agents 73: Structure–activity relationship study and asymmetric synthesis of 3-O-monomethylsuccinyl-betulinic acid derivatives 2007 ·Bioorganic & Medicinal Chemistry Letters ·Keduo Qian,Kyoko Nakagawa‐Goto,Donglei Yu,Susan L. Morris‐Natschke,Theodore J. Nitz,Nicole Kilgore,Graham P. Allaway,Kuo‐Hsiung Lee	29
5	Potent Activity of the HIV-1 Maturation Inhibitor Bevirimat in SCID-hu Thy/Liv Mice 2007 ·PLoS ONE ·Cheryl A. Stoddart,Pheroze Joshi,Barbara Sloan,(unknown),Philip C. Smith,Graham P. Allaway,Carl Wild,David E. Martin	36
6	Determinants of activity of the HIV-1 maturation inhibitor PA-457 2006 ·Virology ·Feng Li,(unknown),(unknown),Nicole Kilgore,(unknown),Abdul S. Yunus,Catherine S. Adamson,Karl Salzwedel,David E. Martin,Graham P. Allaway,Eric O. Freed,Carl Wild	56
7	Computational Studies and Drug Design for HIV-1 Reverse Transcriptase Inhibitors of 3′,4′-di-O-(S)-camphanoyl-(+)-cis-Khellactone (DCK) Analogs 2005 ·Journal of Computer-Aided Molecular Design ·(unknown),(unknown),(unknown),Lan Xie,(unknown),Ting Zhou,Kuo‐Hsiung Lee,Graham P. Allaway	7
8	The discovery of a class of novel HIV-1 maturation inhibitors and their potential in the therapy of HIV 2005 ·Expert Opinion on Investigational Drugs ·Donglei Yu,Carl Wild,David E. Martin,Susan L. Morris‐Natschke,Chin‐Ho Chen,Graham P. Allaway,Kuo‐Hsiung Lee	41
9	3-O-Glutaryl-dihydrobetulin and related monoacyl derivatives as potent anti-HIV agents 2004 ·Bioorganic & Medicinal Chemistry Letters ·Yoshiki Kashiwada,Michiko Sekiya,Yasumasa Ikeshiro,Toshihiro Fujioka,Nicole Kilgore,Carl Wild,Graham P. Allaway,Kuo‐Hsiung Lee	23
10	Anti-AIDS agents. Part 47: synthesis and anti-HIV activity of 3-substituted 3′,4′-Di-O-(S)-camphanoyl-(3′R,4′R)-(+)-cis-khellactone derivatives 2001 ·Bioorganic & Medicinal Chemistry Letters ·Lan Xie,Graham P. Allaway,Carl Wild,Nicole Kilgore,(unknown)	7
11	AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptorbreakdown → 1998 ·Nature Medicine ·(unknown),Dominique Schols,Steven Lin,José A. Esté,Kirsten Nagashima,Paul J. Maddon,Graham P. Allaway,Thomas P. Sakmar,Geoffrey Henson,Erik De Clercq,John P. Moore	634
12	HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5breakdown → 1996 ·Nature ·Tatjana Dragic,Virginia Litwin,Graham P. Allaway,(unknown),Yaoxing Huang,Kirsten Nagashima,Charmagne Cayanan,Paul J. Maddon,Richard A. Koup,JOHN P. MOORE,William A. Paxton	2625
13	CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5breakdown → 1996 ·Nature ·Alexandra Trkola,Tatjana Dragic,James Arthos,James Μ. Binley,William C. Olson,Graham P. Allaway,Cecilia Cheng‐Mayer,James E. Robinson,Paul J. Maddon,John P. Moore	922
14	Expression and Characterization of CD4-IgG ₂ , a Novel Heterotetramer That Neutralizes Primary HIV Type 1 Isolates 1995 ·AIDS Research and Human Retroviruses ·Graham P. Allaway,Karen Davis‐Bruno,Gary A. Beaudry,(unknown),(unknown),(unknown),Karl W. Hasel,Marie‐Claire Gauduin,Richard A. Koup,J. Steven McDougal,Paul J. Maddon	198
15	Synergistic Inhibition of HIV-1 Envelope-Mediated Cell Fusion by CD4-Based Molecules in Combination with Antibodies to gp120 or gp41 1993 ·AIDS Research and Human Retroviruses ·Graham P. Allaway,(unknown),Gary A. Beaudry,Paul J. Maddon	32
16	Prokaryotic expression of the thyrotropin receptor and identification of an immunogenic region of the protein using synthetic peptides 1991 ·Biochemical and Biophysical Research Communications ·Osamu Takai,(unknown),Gattadahalli S. Seetharamaiah,Craig A. Jones,Graham P. Allaway,Takashi Akamizu,Leonard D. Kohn,(unknown)	61
17	A Potential for Mutual Regulation of Proopiomelanocortin Gene and Epstein‐Barr Virus Expression in Human Lymphocytes 1990 ·Annals of the New York Academy of Sciences ·Edward L. Oates,Graham P. Allaway,Bellur S. Prabhakar	6
18	Cell surface expression of the 70-kD component of Ku, a DNA-binding nuclear autoantigen. 1990 ·Journal of Clinical Investigation ·Bellur S. Prabhakar,Graham P. Allaway,J. Srinivasappa,Abner Louis Notkins	87
19	Characterization of the 70kDa component of the human Ku autoantigen expressed in insect cell nuclei using a recombinant baculovirus vector 1990 ·Biochemical and Biophysical Research Communications ·Graham P. Allaway,(unknown),Leonard D. Kohn,Abner Louis Notkins,(unknown)	35
20	Spontaneously Proliferating Human B Lymphocytes Make Autoantibodies 1988 ·The Journal of Infectious Diseases ·Graham P. Allaway,J. Srinivasappa,Frederick W. Miller,Bellur S. Prabhakar,Abner Louis Notkins	8

About Graham P. Allaway

Graham P. Allaway is a scholar working on Virology, Infectious Diseases and Immunology, having authored 47 papers that have together received 6.6k indexed citations. Recurring topics across this work include HIV Research and Treatment (22 papers), HIV/AIDS drug development and treatment (19 papers) and Immune Cell Function and Interaction (11 papers). The work is most often cited by research in Virology (4.8k citations), Immunology (3.2k citations) and Infectious Diseases (2.3k citations). Graham P. Allaway has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Paul J. Maddon, Tatjana Dragic, Kirsten Nagashima, Richard A. Koup, Virginia Litwin, William A. Paxton, JOHN P. MOORE, Yaoxing Huang, Charmagne Cayanan and John P. Moore. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact